EBS - Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q1 2022 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) Q1 2022 Results Conference Call April 28, 2022 05:00 PM ET Company Participants Bob Burrows - VP, IR Bob Kramer - President and CEO Rich Lindahl - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Lisa Springer - Singular Research Presentation Operator Good day, and thank you for standing by. Welcome to the First Quarter 2022 Emergent BioSolutions Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to management. Please go ahead. Bob Burrows Thank you, Victor, and good afternoon, everyone. My name is Bob Burrows, VP and Investor Relations Officer for the Company. Thank you for joining us today, as we discuss the operational and financial results for first quarter 2022. As is customary, today’s call is open to
For further details see:
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q1 2022 Results - Earnings Call Transcript